Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleni Douni

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Arthritis Research & Therapy|February 26, 2004
Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocolsEleni Douni, Petros P Sfikakis, Sylva Haralambous, et al.
Metabolism: Clinical and Experimental|January 29, 2019
Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?Athanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2003
Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic miceKaterina Akassoglou, Eleni Douni, Jan Bauer, et al.
Frontiers in Immunology|February 27, 2019
New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory ArthritisMaria Papadaki, Vagelis Rinotas, Foteini Violitzi, et al.
Arthritis Research & Therapy|September 22, 2009
Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg miceMaung-Maung Thwin, Eleni Douni, Pachiappan Arjunan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Solvent Selection for Insoluble Ligands, a Challenge for Biological Assay Development: A TNF-α/SPD304 StudyChristos P Papaneophytou, Anthi K Mettou, Vagelis Rinotas, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 15, 2021
RANKL-Induced Increase in Cathepsin K Levels Restricts Cortical Expansion in a Periostin-Dependent Fashion: A Potential New Mechanism of Bone FragilityNicolas Bonnet, Eleni Douni, Geneviève Perréard Lopreno, et al.
Biomolecules|May 16, 2023
Inhibition Analysis and High-Resolution Crystal Structure of <i>Mus musculus</i> Glutathione Transferase P1-1Oleksii Kupreienko, Fotini Pouliou, Konstantinos Konstandinidis, et al.
Human Molecular Genetics|November 10, 2011
A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNFEleni Douni, Vagelis Rinotas, Eleni Makrinou, et al.
Frontiers in Pharmacology|August 10, 2018
<i>In Silico</i> Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)Georgia Melagraki, Evangelos Ntougkos, Dimitra Papadopoulou, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Arthritis Research & Therapy|February 26, 2004
Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocolsEleni Douni, Petros P Sfikakis, Sylva Haralambous, et al.
Metabolism: Clinical and Experimental|January 29, 2019
Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?Athanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2003
Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic miceKaterina Akassoglou, Eleni Douni, Jan Bauer, et al.
Frontiers in Immunology|February 27, 2019
New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory ArthritisMaria Papadaki, Vagelis Rinotas, Foteini Violitzi, et al.
Arthritis Research & Therapy|September 22, 2009
Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg miceMaung-Maung Thwin, Eleni Douni, Pachiappan Arjunan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Solvent Selection for Insoluble Ligands, a Challenge for Biological Assay Development: A TNF-α/SPD304 StudyChristos P Papaneophytou, Anthi K Mettou, Vagelis Rinotas, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 15, 2021
RANKL-Induced Increase in Cathepsin K Levels Restricts Cortical Expansion in a Periostin-Dependent Fashion: A Potential New Mechanism of Bone FragilityNicolas Bonnet, Eleni Douni, Geneviève Perréard Lopreno, et al.
Biomolecules|May 16, 2023
Inhibition Analysis and High-Resolution Crystal Structure of <i>Mus musculus</i> Glutathione Transferase P1-1Oleksii Kupreienko, Fotini Pouliou, Konstantinos Konstandinidis, et al.
Human Molecular Genetics|November 10, 2011
A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNFEleni Douni, Vagelis Rinotas, Eleni Makrinou, et al.
Frontiers in Pharmacology|August 10, 2018
<i>In Silico</i> Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)Georgia Melagraki, Evangelos Ntougkos, Dimitra Papadopoulou, et al.
Pageof 5